Outcomes of Patients With Chronic Lung Disease and Severe Aortic Stenosis Treated With Transcatheter Versus Surgical Aortic Valve Replacement or Standard Therapy

被引:96
作者
Dvir, Danny [1 ]
Waksman, Ron [1 ]
Barbash, Israel M. [1 ]
Kodali, Susheel K. [2 ,3 ]
Svensson, Lars G. [4 ]
Tuzcu, E. Murat [4 ]
Xu, Ke [2 ,3 ]
Minha, Sa'ar [1 ]
Alu, Maria C. [2 ,3 ]
Szeto, Wilson Y. [5 ]
Thourani, Vinod H. [6 ]
Makkar, Raj [7 ]
Kapadia, Samir [4 ]
Satler, Lowell F. [1 ]
Webb, John G. [8 ]
Leon, Martin B. [2 ,3 ]
Pichard, Augusto D. [1 ]
机构
[1] MedStar Washington Hosp Ctr, Washington, DC 20010 USA
[2] Columbia Univ, Med Ctr, Ctr Intervent Vasc Therapy, New York, NY USA
[3] Cardiovasc Res Fdn, New York, NY USA
[4] Cleveland Clin Fdn, Sones Cardiac Catheterizat Lab, Cleveland, OH 44195 USA
[5] Hosp Univ Penn, Div Cardiovasc Surg, Philadelphia, PA 19104 USA
[6] Emory Univ, Sch Med, Atlanta, GA USA
[7] Cedars Sinai Heart Inst, Cardiovasc Intervent Ctr, Los Angeles, CA USA
[8] St Pauls Hosp, Ctr Intervent Vasc Therapy, Intervent Cardiol & Cardiac Catheterizat Labs Mar, Vancouver, BC V6Z 1Y6, Canada
关键词
aortic stenosis; pulmonary disease; transcatheter aortic valve replacement; HIGH-RISK PATIENTS; OBSTRUCTIVE PULMONARY-DISEASE; 6-MINUTE WALK TEST; EDWARDS SAPIEN; EUROPEAN REGISTRY; EXERCISE CAPACITY; HEART-FAILURE; IMPLANTATION; MORTALITY; PREDICTORS;
D O I
10.1016/j.jacc.2013.09.024
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives The study aimed to evaluate the impact of chronic lung disease (CLD) on outcomes of severe aortic stenosis patients across all treatment modalities. Background Outcomes of patients with CLD undergoing transcatheter aortic valve replacement (TAVR) have not been systematically examined. Methods All patients who underwent TAVR in the PARTNER (Placement of AoRTic TraNscathetER Valve) trial, including the continued access registry (n = 2,553; 1,108 with CLD), were evaluated according to CLD clinical severity. Additionally, outcomes of CLD patients included in the randomization arms of the PARTNER trial were compared: Cohort A patients (high-risk operable) treated by either TAVR (n = 149) or surgical aortic valve replacement (SAVR); (n = 138); and Cohort B patients (inoperable) treated by either TAVR (n = 72) or standard therapy only (n = 95). Results Among all TAVR-treated patients, at 1-year follow-up, patients with CLD had higher mortality than those without it (23.4% vs. 19.6%, p = 0.02). Baseline characteristics of CLD patients who underwent TAVR were similar to respective controls. In Cohort A, 2-year all-cause death rates were similar (TAVR 35.2% and SAVR 33.6%, p = 0.92), whereas in Cohort B, the death rate was lower after TAVR (52.0% vs. 69.6% after standard therapy only, p = 0.04). Independent predictors for mortality in CLD patients undergoing TAVR included poor mobility (6-min walk test <50 m; hazard ratio: 1.67, p = 0.0009) and oxygen-dependency (hazard ratio: 1.44, p = 0.02). Although CLD patients undergoing TAVR have worse outcomes than patients without CLD, TAVR is better in these patients than standard therapy and is similar to SAVR. Conclusions Although patients with CLD undergoing TAVR had worse outcomes than patients without CLD, TAVR performed better in these patients than standard therapy and was similar to SAVR. However, CLD patients who were either poorly mobile or oxygen-dependent had poor outcomes. (THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial; NCT00530894) (1 Am Coll Cardiol 2014;63:269-79) 2014 (C) by the American College of Cardiology Foundation
引用
收藏
页码:269 / 279
页数:11
相关论文
共 56 条
[1]
Gait Speed as an Incremental Predictor of Mortality and Major Morbidity in Elderly Patients Undergoing Cardiac Surgery [J].
Afilalo, Jonathan ;
Eisenberg, Mark J. ;
Morin, Jean-Francois ;
Bergman, Howard ;
Monette, Johanne ;
Noiseux, Nicolas ;
Perrault, Louis P. ;
Alexander, Karen P. ;
Langlois, Yves ;
Dendukuri, Nandini ;
Chamoun, Patrick ;
Kasparian, Georges ;
Robichaud, Sophie ;
Gharacholou, S. Michael ;
Boivin, Jean-Francois .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (20) :1668-1676
[2]
Exercise Capacity in Patients With Severe Symptomatic Aortic Stenosis Before and Six Months After Transcatheter Aortic Valve Implantation [J].
Bagur, Rodrigo ;
Rodes-Cabau, Josep ;
Dumont, Eric ;
De Larochelliere, Robert ;
Doyle, Daniel ;
Bertrand, Olivier F. ;
Cote, Melanie ;
Poirier, Paul ;
Pibarot, Philippe .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (02) :258-264
[3]
Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation [J].
Bagur, Rodrigo ;
Rodes-Cabau, Josep ;
Dumont, Eric ;
De Larochelliere, Robert ;
Doyle, Daniel ;
Pibarot, Philippe ;
Cote, Melanie ;
Clavel, Marie-Annick ;
Villeneuve, Jacques ;
Gutierrez, Marcos ;
Poirier, Paul ;
Bertrand, Olivier F. .
AMERICAN HEART JOURNAL, 2011, 161 (04) :726-734
[4]
Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic value replacement [J].
Bagur, Rodrigo ;
Webb, John G. ;
Nietlispach, Fabian ;
Dumont, Eric ;
De Larochelliere, Robert ;
Doyle, Daniel ;
Masson, Jean-Bernard ;
Gutierrez, Marcos J. ;
Clavel, Marie-Annick ;
Bertrand, Olivier F. ;
Pibarot, Philippe ;
Rodes-Cabau, Josep .
EUROPEAN HEART JOURNAL, 2010, 31 (07) :865-874
[5]
Preoperative evaluation of the patient with pulmonary disease [J].
Bapoje, Srinivas R. ;
Whitaker, Julia Feliz ;
Schulz, Tara ;
Chu, Eugene S. ;
Albert, Richard K. .
CHEST, 2007, 132 (05) :1637-1645
[6]
The Progression of a Transcatheter Aortic Valve Program: A Decision Analysis of More Than 680 Patient Referrals [J].
Bavaria, Joseph E. ;
Szeto, Wilson Y. ;
Roche, Lauren A. ;
Walsh, Elizabeth K. ;
Buckley-Blaskovich, Virginia ;
Solometo, Lauren P. ;
Burtch, Kristen E. ;
Desai, Nimesh D. ;
Herrmann, Howard C. .
ANNALS OF THORACIC SURGERY, 2011, 92 (06) :2072-2077
[7]
Usefulness of Percutaneous Aortic Valve Implantation to Improve Quality of Life in Patients &gt;80 Years of Age [J].
Bekeredjian, Raffi ;
Krumsdorf, Ulrike ;
Chorianopoulos, Emanuel ;
Kallenbach, Klaus ;
Karck, Mathias ;
Katus, Hugo Albert ;
Rottbauer, Wolfgang .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (12) :1777-1781
[8]
Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation [J].
Ben-Dor, Itsik ;
Pichard, Augusto D. ;
Gonzalez, Manuel A. ;
Weissman, Gaby ;
Li, Yanlin ;
Goldstein, Steven A. ;
Okubagzi, Petros ;
Syed, Asmir I. ;
Maluenda, Gabriel ;
Collins, Sara D. ;
Delhaye, Cedric ;
Wakabayashi, Kohei ;
Gaglia, Michael A., Jr. ;
Torguson, Rebecca ;
Xue, Zhenyi ;
Satler, Lowell F. ;
Suddath, William O. ;
Kent, Kenneth M. ;
Lindsay, Joseph ;
Waksman, Ron .
CIRCULATION, 2010, 122 (11) :S37-S42
[9]
Predictors of "futility" with transcutaneous aortic valve replacement therapy (TAVR): An analysis from the PARTNER randomized trial [J].
Beohar, Nirat ;
Thourani, Vinod ;
Mack, Michael ;
Zajarias, Alan ;
Kapadia, Samir ;
Green, Philip ;
Arnold, Suzanne ;
Cohen, David ;
Xu, Ke ;
Alu, Maria ;
Leon, Martin ;
Kirtane, Ajay .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) :B259-B259
[10]
PREDICTION OF MORTALITY AND MORBIDITY WITH A 6-MINUTE WALK TEST IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION [J].
BITTNER, V ;
WEINER, DH ;
YUSUF, S ;
ROGERS, WJ ;
MCINTYRE, KM ;
BANGDIWALA, SI ;
KRONENBERG, MW ;
KOSTIS, JB ;
KOHN, RM ;
GUILLOTTE, M ;
GREENBERG, B ;
WOODS, PA ;
BOURASSA, MG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (14) :1702-1707